Category News

Niagen Bioscience

Niagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations

Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global leader in NAD+ science and healthy aging, has announced the…

Read MoreNiagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations

Ironwood Pharmaceuticals Reports Strong 2025 Financials and Advances Apraglutide for SBS-IF

Ironwood Strengthens LINZESS Market Leadership and Prepares for Apraglutide Phase 3 Trials Why are biotechnology companies like Ironwood Pharmaceuticals crucial in addressing unmet needs in gastrointestinal diseases? Ironwood Pharmaceuticals, a biotechnology company headquartered in Boston, Massachusetts, is dedicated to developing…

Read MoreIronwood Pharmaceuticals Reports Strong 2025 Financials and Advances Apraglutide for SBS-IF
Mevion Medical

Mevion Medical Systems Receives CE Mark for World’s First LINAC Vault-Ready Proton Therapy System

Regulatory Milestone Enables European Expansion of Advanced Proton Therapy Why is proton therapy still out of reach for many European cancer centers? Mevion Medical Systems, the global leader in compact proton therapy, has announced that the MEVION S250-FIT Proton Therapy…

Read MoreMevion Medical Systems Receives CE Mark for World’s First LINAC Vault-Ready Proton Therapy System